Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (1.55%) to 10276.95, DAX (1.02%) to 24663.61, CAC40 (1.17%) to 8202.08, STOXX 600 (1.10%) to 616.42

May 07 ,2026

  • Synopsis:

    • European indices ended lower with energy, food/beverages, telco and industrials among the main laggards, while travel/leisure, autos and media holding up better. FTSE lagging somewhat amid weakness in energy and utility names. Follows Wednesday's sharp gains.

    • In the UK, local elections in focus with PM Starmer's leadership under intense scrutiny. Press reports in recent days suggest Labour MPs coalescing around a future challenge from Manchester mayor Burnham. May take time to come to fruition as needs to find path back to Westminster. Meanwhile, allies of Health minister Streeting are preparing for a campaign.

    • On macro front in Europe, Riksbank left policy unchanged as expected. Said with inflation below target and economy weak, there is scope to wait and see on policy. Norges Bank hiked key rate by 25 bps to 4.25%, as expected. Highlighted higher inflation and wage growth prospects than previously assumed. Meanwhile, German factory orders beat on Iran war front-running. Construction PMIs from region and UK updates were weak. Eurozone retail sales slightly lower in March.

    • Busy on the earnings calendar, with Swiss Re (SREN.SW), Siemens Healthineers (SHL.GR), Henkel (HEN3.GR), Shell (SHEL.LN) and Intercontinental Hotels (IHG.LN) reporting before the open. In the pharma sector, GSK (GSK.LN) inked a cardiometabolic drug licensing deal worth over $1B, Roche (ROP.SW) acquired PathAI in a deal potentially worth over $1B upfront and in milestones and Novo Nordisk (NOVO.B.DC) received a key UK endorsement for its blockbuster obesity drug Wegovy. Elsewhere, Nexi (NEXI.IM), Telecom Italia (TIT.IIM), Engie (ENGI.FP) also reported. In M&A rumours, Brown-Forman (BF.B) and Pernod Ricard (RI.FP) pick up talks around a deal in the $32/sh range.

    • Looking ahead to tomorrow's EU econ-calendar, key releases will include, amongst others, Germany Mar trade balance, industrial production, and UK Apr house price index - Halifax. Of note, market will be closed in Czech Republic (Liberation Day).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Travel & Leisure +0.81%, Media +0.25%, Autos & Parts +0.28%, Basic Resources +0.05%, Retail +0.21%, Persnl & HHold Goods (0.15%), Banks (0.50%), Technology (0.43%), Construct & Mtls (0.92%), Financial Svcs (0.99%), Insurance (1.06%)

      • Underperformers:

        • Oil & Gas (2.46%), Food & Beverage (2.09%), Telecom (1.87%), Ind Goods & Svcs (1.77%), Utilities (1.68%), Chemicals (1.28%), Health Care (1.13%), Real Estate (1.15%)

    • Macro:

      • EU:

        • EU agreement on US trade deal within reach, says top lawmaker -- Politico

      • UK:

        • Keir Starmer scrambles to resolve dispute over delayed UK defence budget -- FT

        • Starmer to seek even closer ties to EU -- Telegraph

      • Germany:

        • Germany Sees €52B Tax Hole as Iran War Hits Economy -- Bloomberg

        • Germany Plays Down Tensions With Trump Over Iran, Trade -- Bloomberg

      • France:

        • France preps aid for airlines hit by jet fuel price hikes -- Reuters

      • Italy:

        • Meloni and Magyar cement post-Orbán ties -- Politico

    • Company news:

      • Notable Gainers

        • +29.1% AMS.SW (ams-OSRAM CHF14.57, +3.67) -- earnings

        • +17.0% IMMNOV.SS (Immunovia SEK0.20, +0.03) -- earnings

        • +16.7% MRX.GR (Mister Spex €1.21, +0.20) -- earnings

        • +15.8% GFT.GR (GFT Technologies €19.76, +3.00) -- earnings

        • +14.7% HARVIA.FH (Harvia €40.75, +5.25) -- earnings

        • +14.3% HTWS.LN (Helios Towers £2.36, +0.29) -- earnings

        • +13.9% EG7.SS (Enad Global 7 SEK18.08, +2.40) -- earnings

        • +9.9% BEWI.NO (Bewi ASA NOK15.54, +1.40) -- earnings; new CFO

        • +9.6% MSAB.B.SS (Micro Systemation SEK65.80, +6.00) -- guidance

        • +9.5% ZEAL.DC (Zealand Pharma DKK353.50, +29.80) -- earnings; buyback

        • +9.2% LOOMIS.SS (Loomis SEK456.00, +39.20) -- earnings

        • +8.7% BIOG.B.SS (BioGaia SEK123.30, +10.50) -- earnings

        • +8.7% SMHN.GR (SÜSS MicroTec €88.70, +7.05) -- earnings

        • +8.2% AMBEA.SS (Ambea AB SEK140.50, +11.00) -- earnings

        • +8.1% TPE.GR (PVA TePla €41.20, +3.08) -- earnings

        • +8.0% ZIL2.GR (Elringklinger €5.73, +0.44) -- earnings

        • +8.0% HVO.LN (hVIVO plc £0.08, +0.01) -- clinical trial agreement

        • +7.4% JD.LN (JD Sports Fashion £0.69, +0.05) -- earnings

        • +7.3% SGG.SS (Sensys Gatso Group SEK40.70, +2.80) -- earnings

        • +7.0% CLA.B.SS (Cloetta SEK51.95, +3.49) -- Nordea ugprade

        • +7.0% NKR.NO (Nekkar NOK14.15, +0.95) -- earnings

        • +6.8% NFG.LN (Next 15 Group £2.65, +0.17) -- earnings

        • +6.4% ATO.FP (ATOS SE €36.86, +2.22) -- S&P Global Ratings assigns 'B+' issue rating on proposed issuance of €1.2B senior secured notes due 2031

        • +6.1% WEW.GR (Westwing Group €13.75, +0.80) -- earnings

        • +6.1% TRUE.B.SS (Truecaller SEK13.09, +0.78) -- earnings

        • +5.5% SAFH00.GR (SAF-HOLLAND €19.42, +1.00) -- earnings

        • +5.4% HSX.LN (Hiscox £16.31, +0.84) -- trading statement

        • +5.3% ENVI.NA (Envipco Holding €4.78, +0.24) -- supply agreement

        • +5.2% CREO.LN (Creo Medical Group £0.13, +0.01) -- MicroBlate Fine commercial update

        • +5.1% ELK.NO (Elkem NOK29.18, +1.42) -- private placement

        • +4.7% DEZ.GR (Deutz AG €11.41, +0.50) -- earnings

        • +4.4% JSG.LN (Johnson Service Group £1.37, +0.06) -- AGM statement; buyback

        • +4.3% HEN3.GR (Henkel €65.92, +2.74) -- earnings

        • +3.7% TIT.IM (Telecom Italia €0.68, +0.02) -- earnings

        • +3.6% MEDI.NO (MediStim NOK236.00, +8.00) -- earnings

        • +3.5% NOBA.SS (NOBA Bank Group SEK86.30, +2.90) -- earnings

        • +3.5% BGEO.LN (Lion Finance Group £115.70, +3.90) -- earnings

        • +3.2% ITECH.SS (I-Tech SEK67.00, +2.00) -- earnings

        • +2.8% JUN3.GR (Jungheinrich €28.28, +0.72) -- confirms prelim earnings

        • +2.6% VEI.NO (Veidekke NOK179.00, +4.60) -- earnings

        • +2.5% PST.IM (Poste Italiane €23.35, +0.56) -- earnings

        • +2.4% NAS.NO (Norwegian Air Shuttle NOK14.92, +0.35) -- Apr traffic

        • +2.4% BSL.GR (Basler €23.65, +0.55) -- target up at Berenberg, Jefferies

        • +2.4% SUY1V.FH (Suominen €1.02, +0.02) -- earnings

        • +2.3% KETL.LN (Strix Group £0.43, +0.01) -- trading update

        • +1.9% GARO.SS (GARO SEK12.04, +0.22) -- agreement

        • +1.9% VIVA.SS (Viva Wine Group SEK33.20, +0.60) -- earnings

      • Notable Decliners

        • -26.9% INTRUM.SS (Intrum SEK29.84, -9.94) -- earnings; equity raise

        • -25.8% PHARM.NA (Pharming Group €1.17, -0.36) -- earnings

        • -15.5% AZT.NO (ArcticZymes Technologies NOK22.60, -3.70) -- earnings

        • -14.5% CPR.IM (Davide Campari-Milano €5.79, -0.95) -- earnings

        • -9.1% VATN.SW (Valiant Holding CHF158.60, -16.40) -- earnings

        • -8.7% DMRE.GR (DEMIRE Deutsche Mittelstand Real Estate €0.43, -0.04) -- earnings

        • -8.5% SMOP.NO (Smartoptics Group NOK52.00, -4.80) -- earnings

        • -8.5% EXL.GR (Exasol €2.45, -0.21) -- earnings

        • -8.3% MAERSK.B.DC (Maersk DKK14,745.00, -1,270.00) -- earnings

        • -7.3% SOLB.BB (Solvay €26.44, -2.12) -- earnings

        • -6.9% RHM.GR (Rheinmetall €1,403.20, -100.00) -- reaffrims prelim earnings

        • -6.7% GN.DC (GN Store Nord DKK100.00, -6.98) -- earnings

        • -6.0% ROVI.SM (Laboratorios Farmaceuticos Rovi, S.A. €63.25, -4.05) -- BNP Paribas Exane, Oddo downgrades

        • -5.9% TE.FP (Technip Energies €38.66, -2.36) -- share placing

        • -5.7% FRACTL.SS (Fractal Gaming Group SEK13.28, -0.86) -- earnings

        • -5.6% LXS.GR (Lanxess €16.55, -1.01) -- earnings

        • -5.2% CNA.LN (Centrica £2.00, -0.11) -- AGM statement; acquisition

        • -4.7% BA.LN (BAE Systems £20.31, -0.98) -- trading statement

        • -4.7% SHL.GR (Siemens Healthineers €34.39, -1.68) -- earnings

        • -4.6% MNTC.SS (Mentice SEK12.50, -0.60) -- earnings

        • -4.5% REL.LN (RELX £24.97, -1.15) -- Morgan Stanley downgrade

        • -4.4% MING.NO (SpareBank 1 SMN NOK195.98, -9.00) -- earnings

        • -3.9% AKRBP.NO (Aker BP NOK330.70, -13.30) -- earnings

        • -3.3% BPE.IM (BPER Banca €12.91, -0.44) -- earnings

        • -3.2% SREN.SW (Swiss Re CHF123.60, -4.10) -- earnings

        • -3.1% RI.FP (Pernod Ricard €65.46, -2.04) -- Brown-Forman and Pernod Ricard pick up talks around a deal in the $32/sh range; comments attributed to betaville

        • -3.1% EQNR.NO (Equinor NOK337.60, -10.90)

        • -3.0% ELE.SM (Endesa €36.68, -1.13) -- earnings

        • -2.9% SHEL.LN (Shell Plc £31.31, -0.93) -- earnings, buyback

        • -2.7% TEKNA.NO (Tekna Holding NOK3.69, -0.10) -- earnings

        • -2.5% HAYPP.SS (Haypp Group SEK126.20, -3.20) -- earnings

        • -2.3% NONG.NO (SpareBank 1 Nord-Norge NOK147.76, -3.48) -- earnings

        • -2.3% CCH.LN (Coca-Cola HBC £42.59, -1.02) -- sales

        • -2.2% PGH.LN (Personal Group Holdings £3.69, -0.09) -- AGM statement

        • -2.1% ODF.NO (Odfjell NOK111.00, -2.40) -- earnings

        • -1.7% LR.FP (Legrand €166.05, -2.70) -- earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • DACHs: Commerzbank (CBK.GR), Evonik Industries (EVK.GR), Krones (KRN.GR), Bechtle (BC8.GR), Clariant (CLN.SW), Lonza Group (LONN.SW), Oesterreichische Post (POST.AV)

        • Nordics: Aker (AKER.NO), Höegh Autoliners (HAUTO.NO), AKVA Group (AKVA.NO), Hofseth BioCare (HBC.NO), Synsam (SYNSAM.SS), Fastighets Balder (BALD.B.SS), Sagax (SAGA.B.SS), Karnell Group (KARNEL.B.SS), Catella (CAT.B.SS), Pierce Group (PIERCE.SS), Duroc (DURC.B.SS), Oneflow (ONEF.SS), Mendus (IMMU.SS), Mandatum (MANTA.FH), Teleste (TLT1V.FH), Tokmanni Group (TOKMAN.FH), MT Hojgaard Holding (MTHH.DC)

        • Other: MOL Hungarian Oil & Gas (MOL.HB)

        • Southern Europe: Intesa Sanpaolo (ISP.IM), Sanlorenzo (SL.IM), Piaggio & C (PIA.IM), Amadeus IT Group (AMS.SM), Acerinox (ACX.SM), National Bank of Greece (ETE.GA), Hellenic Telecommunications Organization (HTO.GA), Sonaecom SGPS (SNC.PL)

        • UK: International Consolidated Airlines Group (IAG.LN), Airtel Africa (AAF.LN)

      • Trading Statement:

        • Benelux: Sif Holding (SIFG.NA), Brunel International (BRNL.NA)

  • Data:

    • Economics:

      • Eurozone Mar Retail Sales +1.2% y/y vs consensus +1.0% and prior revised to +1.3% from +1.7%

      • Germany

        • Mar

          • Factory Orders m/m +5.0% vs consensus +1.1% and prior revised to +1.4% from +0.9%

          • Industrial Production y/y +0.7% vs consensus n/a and prior (1.3%)

        • Apr Construction PMI 42.1 vs consensus 49.0 and prior 48.0

      • France Mar Trade Balance (€6.9B) vs consensus (€5.7B) and prior revised to (€5.5B) from (€5.8B)

      • UK Apr Construction PMI 39.7 vs consensus 45.7 and prior 45.6

      • Switzerland Apr Unemployment rate (sa) 3.0% vs consensus 3.1% and prior 3.1%

    • Markets:

      • WTI Crude (26-Jun): ($3.14) or (3.30%) to $91.94

      • €-$ +0.0024 or +0.20% to 1.1772

      • £-$ +0.0026 or +0.19% to 1.3618

      • €-£ +0.0002 to 0.8646

      • S&P 500 +0.13%

      • Performance year-to-date:

        • FTSE 100: +3.48%

        • DAX: +0.71%

        • CAC: +0.65%

        • MIB: +9.67%

        • Stoxx 600: +4.09%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.